Loading...

AYTU AYTU BIOPHARMA INC Capital Structure Changes 8-K Filing

YT B

YT

AYTU BIOPHARMA INC

(AYTU)

2025 8-K

Show Summary

Show Summary

Product Overview

Equity Offerings

Rights Offerings

Financial Statements

Court Settlement Hearing

Management Changes

Earnings Announcement

Sale of Consumer Health Bus...

Annual Meeting of Stockholders

Loan Agreement Amendment

Agreement with Halo Pharmac...

Results of Operations and F...

Resignation of COO

Earnings Release

Agreement Announcement

Securities Purchase Agreeme...

Annual Meeting of Stockholders

Earnings Report

Sublease Agreement

FDA Approval and Study Comp...

Discussions for Strategic T...

Loan Agreement Amendment

Earnings Reports

Financial Restatement

Management Agreements Amended

Compliance with Nasdaq List...

Reverse Stock Split

External Links:

On May 21, 2025, Aytu BioPharma approved an amendment increasing the shares in its 2023 Equity Incentive Plan by 300,000 to a total of 500,000 shares. Additionally, all incumbent directors were re-elected, and other proposals regarding accounting fir

AI Assistant

AYTU BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.